Lyra Therapeutics Inc. (LYRA)
NASDAQ: LYRA
· Real-Time Price · USD
7.06
-0.04 (-0.56%)
At close: Aug 15, 2025, 3:59 PM
6.91
-2.12%
After-hours: Aug 15, 2025, 04:40 PM EDT
Lyra Therapeutics Fail-to-Deliver
Total FTD Shares
1.13K
Below Average
FTD / Avg. Volume
0.17%
Low Impact
1-Year Change
-88.8%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Lyra Therapeutics Inc. has
1,134
shares failed to deliver, representing 0.17%
of the average daily volume of
665,204
shares. Over the past year, the monthly average FTD is
37,371
shares, with the current level 97% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 8.71 | 1.13K | -90.84% |
Jun 30, 2025 | 8.96 | 12.38K | +3959.34% |
May 30, 2025 | 4.93 | 305 | -99.69% |
Apr 30, 2025 | 5.94 | 98.05K | +229.29% |
Mar 26, 2025 | 7.8 | 29.77K | +119000.00% |
Feb 28, 2025 | 10.7 | 25 | -99.79% |
Jan 14, 2025 | 9.46 | 11.84K | -46.40% |
Dec 26, 2024 | 9.03 | 22.1K | -17.28% |
Nov 29, 2024 | 10.36 | 26.71K | +304.31% |
Oct 22, 2024 | 12.6 | 6.61K | -95.70% |
Sep 25, 2024 | 13.47 | 153.64K | +2524.55% |
Aug 20, 2024 | 16.3 | 5.85K | +220.77% |
Jul 31, 2024 | 16.27 | 1.82K | -96.66% |
Jun 27, 2024 | 13.06 | 54.59K | +7503.48% |
May 29, 2024 | 16.55 | 718 | +43.60% |
Apr 24, 2024 | 261.5 | 500 | +63.93% |
Mar 25, 2024 | 308 | 305 | +271.95% |
Feb 29, 2024 | 263 | 82 | -67.59% |
Jan 03, 2024 | 252 | 253 | -27.71% |
Dec 05, 2023 | 177 | 350 | +1106.90% |
Nov 28, 2023 | 170 | 29 | -93.89% |
Oct 26, 2023 | 165.5 | 475 | -61.94% |
Sep 19, 2023 | 240 | 1.25K | +117.80% |
Aug 09, 2023 | 164.5 | 573 | +76.31% |
Jul 28, 2023 | 165 | 325 | +282.35% |
Jun 30, 2023 | 205.5 | 85 | -99.98% |
May 31, 2023 | 128.5 | 367.86K | +1046.60% |
Apr 28, 2023 | 120 | 32.08K | +356377.78% |
Mar 30, 2023 | 104 | 9 | -99.87% |
Feb 27, 2023 | 115.5 | 7.12K | +427.41% |
Jan 31, 2023 | 142.5 | 1.35K | n/a |